Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Four-meter gait speed predicts daily physical activity in patients with chronic respiratory diseases.

Yoshida C, Ichiyasu H, Ideguchi H, Hirosako S, Masunaga A, Kojima K, Saeki S, Fujii K, Sakagami T, Kohrogi H.

Respir Investig. 2019 May 13. pii: S2212-5345(18)30221-1. doi: 10.1016/j.resinv.2019.03.009. [Epub ahead of print]

PMID:
31092319
2.

Characteristics and association with survival of respiratory-related hospitalization in Japanese idiopathic pulmonary fibrosis patients.

Nishiyama O, Saeki S, Yamazaki R, Sano H, Iwanaga T, Kume H, Tohda Y.

Respir Investig. 2019 Apr 16. pii: S2212-5345(18)30316-2. doi: 10.1016/j.resinv.2019.03.005. [Epub ahead of print]

PMID:
31003952
3.

Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer.

Hamada S, Ichiyasu H, Ikeda T, Inaba M, Kashiwabara K, Sadamatsu T, Sato N, Akaike K, Okabayashi H, Saruwatari K, Tomita Y, Saeki S, Hirata N, Yoshinaga T, Fujii K.

BMC Pulm Med. 2019 Apr 2;19(1):72. doi: 10.1186/s12890-019-0838-2.

4.

Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases.

Saruwatari K, Ikeda T, Saeki S, Shingu N, Imamura K, Komatu T, Ushijima S, Maruyama H, Kashiwabara K, Tomita Y, Ichiyasu H, Fujii K, Sakagami T.

Anticancer Res. 2019 Feb;39(2):923-931. doi: 10.21873/anticanres.13195.

PMID:
30711977
5.

The Risks and Benefits of Immune Checkpoint Blockade in Anti-AChR Antibody-Seropositive Non-Small Cell Lung Cancer Patients.

Saruwatari K, Sato R, Nakane S, Sakata S, Takamatsu K, Jodai T, Mito R, Horio Y, Saeki S, Tomita Y, Sakagami T.

Cancers (Basel). 2019 Jan 24;11(2). pii: E140. doi: 10.3390/cancers11020140.

6.

Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing.

Mizugaki H, Hamada A, Shibata T, Hosoda F, Nakamura H, Okuma Y, Shukuya T, Umemura S, Horiike A, Fukui T, Kogure Y, Daga H, Urata Y, Yamada K, Saeki S, Fujisaka Y, Nakamura Y, Sato M, Yoshida T, Hotta T, Oizumi S, Fujiwara Y, Ohe Y, Fujiwara Y.

Lung Cancer. 2019 Feb;128:20-25. doi: 10.1016/j.lungcan.2018.12.002. Epub 2018 Dec 4.

PMID:
30642448
7.

Acute Exacerbation of Idiopathic Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma after Transcatheter Arterial Therapy Using Miriplatin.

Kakiuchi Y, Sakata S, Nakamura K, Okabayashi H, Akaike K, Tokunaga T, Saeki S, Fujii K, Ichiyasu H.

Intern Med. 2019 May 1;58(9):1329-1333. doi: 10.2169/internalmedicine.1446-18. Epub 2019 Jan 10.

8.

A potential mechanism of the onset of acute eosinophilic pneumonia triggered by an anti-PD-1 immune checkpoint antibody in a lung cancer patient.

Jodai T, Yoshida C, Sato R, Kakiuchi Y, Sato N, Iyama S, Kimura T, Saruwatari K, Saeki S, Ichiyasu H, Fujii K, Tomita Y.

Immun Inflamm Dis. 2019 Mar;7(1):3-6. doi: 10.1002/iid3.238. Epub 2018 Nov 21.

9.

Negative Impact of Coexisting Interstitial Lung Disease on Clinical Outcomes in Small-cell Lung Cancer Patients.

Akaike K, Saruwatari K, Okabayashi H, Hamada S, Jodai Y, Jodai T, Sakata S, Iyama S, Sato R, Iriki T, Tomita Y, Saeki S, Ichiyasu H, Fujii K.

Anticancer Res. 2018 Nov;38(11):6543-6550. doi: 10.21873/anticanres.13020.

PMID:
30396984
10.

Respiratory evaluation of the risk for postoperative pulmonary complications in patients who preoperatively consulted pulmonologists: Studying both patients who underwent and who precluded planned surgery.

Hirosako S, Nakamura K, Hamada S, Sugahara K, Yoshida C, Saeki S, Kojima K, Okamoto S, Ichiyasu H, Fujii K, Kohrogi H.

Respir Investig. 2018 Nov;56(6):448-456. doi: 10.1016/j.resinv.2018.07.005. Epub 2018 Aug 23.

PMID:
30146353
11.

Trousseau's syndrome triggered by an immune checkpoint blockade in a non-small cell lung cancer patient.

Horio Y, Takamatsu K, Tamanoi D, Sato R, Saruwatari K, Ikeda T, Nakane S, Nakajima M, Saeki S, Ichiyasu H, Fujii K, Tomita Y.

Eur J Immunol. 2018 Oct;48(10):1764-1767. doi: 10.1002/eji.201847645. Epub 2018 Jul 19.

PMID:
29981156
12.

Successful treatment by pembrolizumab in a patient with end-stage renal disease with advanced non-small cell lung cancer and high PD-L1 expression.

Ishizuka S, Sakata S, Yoshida C, Takaki A, Saeki S, Nakamura K, Fujii K.

Respir Investig. 2018 Jul;56(4):361-364. doi: 10.1016/j.resinv.2018.03.005. Epub 2018 May 10.

PMID:
29764752
13.

Lung abscess following bronchoscopy due to multidrug-resistant Capnocytophaga sputigena adjacent to lung cancer with high PD-L1 expression.

Migiyama Y, Anai M, Kashiwabara K, Tomita Y, Saeki S, Nakamura K, Okamoto S, Ichiyasu H, Fujii K, Kohrogi H.

J Infect Chemother. 2018 Oct;24(10):852-855. doi: 10.1016/j.jiac.2018.03.017. Epub 2018 Apr 25.

PMID:
29703650
14.

Severe interstitial pneumonia associated with anti-PD-1 immune checkpoint antibody after talc slurry pleurodesis.

Sakata S, Matsuoka Y, Kawahara K, Kakiuchi Y, Takaki A, Hirosue A, Yoshida R, Saeki S, Fujii K, Nakayama H.

Respir Investig. 2018 Mar;56(2):195-198. doi: 10.1016/j.resinv.2017.11.006. Epub 2017 Dec 21.

PMID:
29548660
15.

Reversible Restrictive Lung Disease in Pseudomesotheliomatous Carcinoma in a Lung Harboring a HER2-mutation.

Sakata S, Sakamoto Y, Takaki A, Ishizuka S, Saeki S, Fujii K.

Intern Med. 2018 Aug 1;57(15):2223-2226. doi: 10.2169/internalmedicine.9612-17. Epub 2018 Mar 9.

16.

Population Pharmacokinetics and Adverse Events of Erlotinib in Japanese Patients with Non-small-cell Lung Cancer: Impact of Genetic Polymorphisms in Metabolizing Enzymes and Transporters.

Endo-Tsukude C, Sasaki JI, Saeki S, Iwamoto N, Inaba M, Ushijima S, Kishi H, Fujii S, Semba H, Kashiwabara K, Tsubata Y, Hayashi M, Kai Y, Saito H, Isobe T, Kohrogi H, Hamada A.

Biol Pharm Bull. 2018;41(1):47-56. doi: 10.1248/bpb.b17-00521.

17.

Long-term complete response to carboplatin plus paclitaxel combined with bevacizumab in a patient with metastatic spindle cell carcinoma.

Sakata S, Saeki S, Sato R, Ishizuka S, Sasaki J, Fujii K.

Respir Investig. 2017 Nov;55(6):372-375. doi: 10.1016/j.resinv.2017.08.005. Epub 2017 Oct 6.

PMID:
29153418
18.

A Favorable Response to Levetiracetam in a Patient with Metastatic Adenoid Cystic Carcinoma.

Sakata S, Saeki S, Terasaki Y, Natori Y, Fujii K.

Intern Med. 2018 Mar 1;57(5):721-724. doi: 10.2169/internalmedicine.9300-17. Epub 2017 Nov 20.

19.

Small-cell Lung Cancer Associated with SAPHO Syndrome.

Imamura K, Sakata S, Sakamoto Y, Saeki S.

Intern Med. 2018 Jan 1;57(1):149-151. doi: 10.2169/internalmedicine.9162-17. Epub 2017 Oct 16. No abstract available.

20.

Supplemental Content

Loading ...
Support Center